Also in Health and Wellness
Why We Shouldn't Fear Cloned Meat
Annalee Newitz
Leading Dems Miss the Boat on Health Care
John P. Geyman
Blaming Your Genes for Your Health Problems? Not so Fast.
Jamie D. Brooks, Meredith L. King
Digging In the Right Place
David Sirota
Are You Eating Cloned Beef?
Alec Baldwin
Should Tobacco Companies Be Required to Reduce Their Number of Customers?
Stephen D. Sugarman
It's possible to read all 300-plus horrifying pages of a new Food and Drug Administration subcommittee report describing the agency's slow asphyxiation by prolonged budgetary constraints without learning who is responsible for its decline.
Subcommittee member and attorney Peter Barton Hutt, who served as FDA chief counsel during the Nixon and Ford administrations, pointed his finger at the American public in his own supplemental contribution to the report: "It is not a problem caused by partisan politics. The administrations of President Clinton and President Bush have been equally unresponsive to FDA's needs ... The country cannot withhold the requisite scientific resources from FDA and then complain that the agency is incapable of meeting our expectations."
But if everyone is to blame, then no one is. Recent fiascoes like the Melamine-tainted pet food and lead-laced Mattel toys, both imported from China, are sure to continue in the absence of meaningful accountability. The truth is that the carnage described in the report is as much a conservative-movement accomplishment as the creation of the FDA was a great progressive-era triumph.
For many decades, the right has been about as hostile toward the FDA as it has been toward Social Security -- another long-standing success story that undercuts the worldview that government is the problem rather than the solution. In a 1975 roundtable at the American Enterprise Institute, for example, Ronald Reagan claimed that the FDA was needlessly killing Americans. Referring to the drug Rifampin, he said, "I think something more than 40,000 tuberculars alone have died in this country who conceivably could have been saved by a drug that has been widely used the past few years throughout Europe." In fact, Rifampin had already been on the market in the U.S. for four years, approved by the FDA five months after the manufacturer submitted the application.
The network of conservative and libertarian think tanks that began to sprout in the years leading up to Reagan's presidency, blossoming in full during his eight years in office, continued to hammer away at his theme of FDA as murderer, pointing to its purportedly unreasonable delays in approving drugs and medical devices. The evidence they marshaled in support of that claim wasn't much stronger than Reagan's Rifampin fiction, but over time the sheer repetition of the argument gained traction. It's worth noting that many of those same right-wing institutions demonstrated considerably less concern for the public's health when they incongruously chastised the agency for its unfair harassment of tobacco companies.
Another persistent line of attack was most concisely expressed by Newt Gingrich, who dubbed the FDA the "number-one job killer in America." That accusation was applauded by the pharmaceutical, medical-device, and food industry funders of both the Republican Party and conservative think tanks, reinforcing their threats to relocate to countries with less stringent regulatory oversight.
Charting the phases of the FDA's decline lays bare the responsibility borne by movement conservatism. The first phase was the two terms of the Reagan presidency, when the FDA's staff declined by 30 percent. After a reprieve from 1988 to 1994, when more moderate presidents and a Democratic Congress provided ample boosts in the agency's budget and staffing, the FDA's garroting resumed with a vengeance in the wake of the 1994 Republican landslide that catapulted Gingrich to the House Speaker's chair. He led a highly effective jihad against the agency, pushing to privatize many of its activities. The onslaught continued under George W. Bush and the Republican Congress. From 1994 to 2007, according to former FDA chief counsel Hutt, the agency's appropriated personnel declined from 9,167 to 7,856, while its funding increased by only two-thirds of the amount that would have been needed to keep up with inflation.
See more stories tagged with: reagan, conservative, fda








No comments:
Post a Comment